Primrose Bio announced a new product to improve the manufacturing on long-template mRNA vaccines. 1 The Prima RNApols ExTend ...

Strongrevenueperformance,includingapproximately$1.9millionmilestoneandlicenserevenuerecognizedin2024Up to $7.5 million in grants awarded from ...

BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by ...

They found a new molecule named lariocidin —a potential new antibiotic with the power to kill some of the world’s most ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 million in grants awarded from CEPI and Gates Foundation intended to acceler ...

Biopharmaceutical company BioVersys has announced the grant of key patent claims in China for BV100, the intravenous ...

To implement the blueprint it contains, RNA polymerase is used. The enzyme reads the information stored in the template and ...

Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...

Bloodstream infections require rapid identification to prevent complications, yet standard diagnostic methods rely on polymerase ... caged RNA that activates more Cas12a enzymes in the T2 complex.

DNA polymerase beta (Pol β) is the primary enzyme responsible for processing 1-nt gaps in chromatin during DNA repair. Here, the authors determine the kinetic and structural basis of gap-filling ...